For the same reason it’s trading at or below cash, I’m adding, not selling. These prices are an opportunity. I’ll keep taking advantage of cheap shares while the market offers them. Hoping it stays down through Friday — expecting more dry powder.
I'll assume thats part of a well diversified portfolio I''m surprised you aren't in UNCY given your background in the field . For whats its worth ...I'm still taking Vascepa ...however Kaiser for now is only sending me the generic version made by Camber pharma. Its $10 for 100 day supply And thats the challenge for AMRN ...competing against the generics in the US market . Maybe that changes with the legal action underway Good luck Kiwi
Market Data 
Markets 
AI
